Register of Therapeutical Patients Over 60 Years

Men Clinical Trial

— ASCLEPIUS  

Official title:

Register on the Study of Prevalence and Incidence, Risk Factors and Outcomes of Hospitalizations in Older Age Groups in Eurasia.

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04295057
• Other study ID #: EUAT
• Secondary ID: ASCLEPIUS
• Status: Not yet recruiting
• Start date: January 15, 2023
• Est. completion date: March 15, 2024

Study information

• Verified date: February 2022
• Source: Eurasian Association of Therapists
• Contact: Alexandra Deeva
• Phone: +79033777940
• Email: adeeva[@]euat.ru
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Register for the study of the prevalence and burden of diseases, risk factors and outcomes of hospitalizations in older age groups in the countries of Eurasia.

Description:

An open, multicenter registry to track all major noncommunicable diseases and risk factors in older age groups, prescribed drugs, and disease outcomes.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 12000
• Est. completion date: March 15, 2024
• Est. primary completion date: March 15, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• over 60 years
• Appointment to a doctor of a therapeutic profile

Exclusion Criteria:

• Reluctance of the Patient to participate in the Register;
• Age under 60 at the time of inclusion in the Register.

Related Conditions & MeSH terms

• Age Problem
• Men
• Therapeutic Alliance

Intervention

Other:
• Non-intervention
Non-intervention

Locations

Country	Name	City	State
Russian Federation	Eurasian Association of Therapists	Moscow

Sponsors (1)

Lead Sponsor	Collaborator
Eurasian Association of Therapists

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence	Incidence of non-infectious diseases	12 months
Primary	Non-infectious diseases	Age-related non-infectious diseases dynamics of the development of the main after 60 years	12 months
Primary	Age groups	The prevalence of various non-infectious diseases in different age groups	12 months
Primary	Therapy	Names, doses and duration of prescribed therapy	12 months
Primary	Drugs	Analysis of prescribed therapy and calculation of losses from improper treatment due to repeated hospitalizations, disability and complications	12 months
Primary	Measure criteria	12000 patients	12 months